• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

which can help to speed up our understanding of how treatments may work for a new health condition.” GLP-1 receptor agonists may influence the very mechanisms within the brain that regulate ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

receptor agonists. These medications mimic the action of the natural hormone GLP-1, which the gut releases after eating. This article asks whether peptides really work for weight loss, discusses ...

Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared ... “These medications work from a weight ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Mounjaro is a type of drug called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist ... Mounjaro does not cause hair loss as a side ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...